The exclusive formula of the drug features an undeniable ability to overcome body bacteria fast and without extra effort. The therapy is fully safe if a patient follows all the instructions and individual safety directions.

CAC File Library

NOTE: These documents are for members only, and will require a member login. If there is a document you need that is not linked on this page, please contact Danielle Meyer at

If you need to contact someone about your login information, please contact Wendy Gale at

Past Meetings

Click here to view past materials for the Compliance Advisory Committee.  Note that this is a members-only resource library.


Additional Resources and Guidelines
Media Code of Conduct - DRAFT Mandatory PHI Disclosures in Oregon HIPAA and Law Enforcement
SB 469 Notice for Posting Discharge Planning for Patients Hospitalized for Mental Health Treatment, draft as of Dec. 2, 2015 OHP Enrollment Outreach Coordinators List
OHA Monthly Report of Death Fillable Form Guide to Federal Hospital Signage Requirements Disclosure Laws
2013 Report to the Oregon Legislature: Advisory Committee on Genetic Privacy and Research    

    Policy Team

    Sean Kolmer, MPH
    Senior Vice President of Policy & Strategy

    Danielle Meyer, MSS
    Director of Public Policy

    Rebecca Pawlak, MPH
    Director of Public Policy